Search Results - "Di Martino, M T"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Promises and challenges of MicroRNA-based treatment of multiple myeloma by Tagliaferri, P, Rossi, M, Di Martino, M T, Amodio, N, Leone, E, Gulla, A, Neri, A, Tassone, P

    Published in Current cancer drug targets (01-09-2012)
    “…MicroRNAs (miRNAs) recently emerged with a key role in multiple myeloma (MM) pathophysiology and are considered important regulators of MM cell growth and…”
    Get more information
    Journal Article
  2. 2

    Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma by Tassone, P, Neri, P, Burger, R, Di Martino, M T, Leone, E, Amodio, N, Caraglia, M, Tagliaferri, P

    Published in Current cancer drug targets (01-09-2012)
    “…Mouse models of multiple myeloma (MM) are basic tools for translational research and play a fundamental role in the development of new therapeutics against…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo by Morelli, E, Leone, E, Cantafio, M E Gallo, Di Martino, M T, Amodio, N, Biamonte, L, Gullà, A, Foresta, U, Pitari, M R, Botta, C, Rossi, M, Neri, A, Munshi, N C, Anderson, K C, Tagliaferri, P, Tassone, P

    Published in Leukemia (01-11-2015)
    “…Interferon regulatory factor 4 (IRF4) is an attractive therapeutic target in multiple myeloma (MM). We here report that expression of IRF4 mRNA inversely…”
    Get full text
    Journal Article
  5. 5

    MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells by Botta, C, Cucè, M, Pitari, M R, Caracciolo, D, Gullà, A, Morelli, E, Riillo, C, Biamonte, L, Gallo Cantafio, M E, Prabhala, R, Mignogna, C, Di Vito, A, Altomare, E, Amodio, N, Di Martino, M T, Correale, P, Rossi, M, Giordano, A, Munshi, N C, Tagliaferri, P, Tassone, P

    Published in Leukemia (01-04-2018)
    “…Dendritic cells (DCs) have a key role in regulating tumor immunity, tumor cell growth and drug resistance. We hypothesized that multiple myeloma (MM) cells…”
    Get full text
    Journal Article
  6. 6

    Psychrophilic superoxide dismutase from Pseudoalteromonas haloplanktis: biochemical characterization and identification of a highly reactive cysteine residue by Castellano, I., Di Maro, A., Ruocco, M.R., Chambery, A., Parente, A., Di Martino, M.T., Parlato, G., Masullo, M., De Vendittis, E.

    Published in Biochimie (01-10-2006)
    “…A psychrophilic superoxide dismutase (SOD) has been characterized from the Antarctic eubacterium Pseudoalteromonas haloplanktis ( Ph). PhSOD is a homodimeric…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Development and validation of a bioanalytical method for quantification of LNA-i-miR-221, a 13-mer oligonucleotide, in rat plasma using LC–MS/MS by Franzoni, S., Vezzelli, A., Turtoro, A., Solazzo, L., Greco, A., Tassone, P., Di Martino, M.T., Breda, M.

    “…•An ion-pair reversed-phase LC–MS/MS method for the determination of LNA-i-miR-221, a 13-mer oligonucleotide, in rat plasma was developed and…”
    Get full text
    Journal Article
  9. 9

    A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival by Botta, C, Di Martino, M T, Ciliberto, D, Cucè, M, Correale, P, Rossi, M, Tagliaferri, P, Tassone, P

    Published in Blood cancer journal (New York) (16-12-2016)
    “…Multiple myeloma (MM) is closely dependent on cross-talk between malignant plasma cells and cellular components of the inflammatory/immunosuppressive bone…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario by Rossi, Marco, Amodio, Nicola, Di Martino, M T, Caracciolo, Daniele, Tagliaferri, Pierosandro, Tassone, Pierfrancesco

    Published in Current drug targets (01-09-2013)
    “…The progress in the understanding of biological events underlying multiple myeloma (MM) development and progression has allowed the design of molecularly…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Differential transcriptional response to cisplatinum in BRCA1-defective versus BRCA1-reconstituted breast cancer cells by microarrays by Di Martino, MT, Ventura, M, Guzzi, PH, Pietragalla, A, Neri, P, Bulotta, A, Calimeri, T, Barbieri, V, Caraglia, M, Veltri, P, Cannataro, M, Tassone, P, Tagliaferri, P

    Published in Cancer research (Chicago, Ill.) (15-01-2009)
    “…Abstract Abstract #5062 BRCA1-related breast cancer represents a distinct clinical entity characterized by basal-like molecular phenotype. HCC1937 is a…”
    Get full text
    Journal Article
  16. 16

    EDTA is essential to recover lead from dried blood spots on filter paper by Di Martino, Maria T., Michniewicz, Andzelika, Martucci, Maria, Parlato, Giuseppe

    Published in Clinica chimica acta (01-12-2004)
    “…Residual dried blood spots (DBSs) on filter paper from neonatal screening have been proposed as samples for population survey of lead contamination. We have…”
    Get full text
    Journal Article
  17. 17

    Areas in Calabria with an elevated incidence of congenital hypothyroidism and iodine content of drinking water by Di Martino, M T, Martucci, M, Filippelli, P, Scalzo, R, Parlato, G

    “…The screening of 128,442 newborns, carried out in our laboratory from 1/1/1991 to 31/12/1996, detected 51 cases of congenital hypothyroidism (CH). Due to a 98%…”
    Get more information
    Journal Article